SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,642.43 |
| Enterprise Value ($M) | 2,366.31 |
| Book Value ($M) | -468.56 |
| Book Value / Share | -2.24 |
| Price / Book | -3.51 |
| NCAV ($M) | -544.39 |
| NCAV / Share | -2.61 |
| Price / NCAV | -3.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.58 |
| Current Ratio | 2.63 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 421.97 |
| Assets | 490.42 |
| Liabilities | 966.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 450.71 |
| Operating Income | -1.28 |
| Net Income | -88.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -52.02 |
| Cash from Investing | 52.59 |
| Cash from Financing | -5.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.81 | 0.00 | |
| 13G/A | State Street Corp | 4.30 | -30.74 | |
| 13G/A | BlackRock, Inc. | 10.20 | 12.64 | |
| 13G | Avoro Capital Advisors LLC | 6.40 | ||
| 13G/A | Baker Bros. Advisors Lp | 4.98 | -46.81 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 638,344 | 3,703,326 | 17.24 | |
| 997,416 | 4,171,357 | 23.91 | |
| 838,884 | 4,279,551 | 19.60 | |
| 1,450,889 | 6,166,754 | 23.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVIR – Atea Pharmaceuticals, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
| BEAM – Beam Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io